Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cohesion Biosciences, also known as Cohesion Biotec, is a global biotechnology company specializing in the development and supply of high-quality research reagents for the life sciences community. The company offers an extensive catalog of over 30,000 validated antibodies, 10,000 ELISA kits, and a wide range of siRNA and small molecule inhibitors used in proteomics and genomics research. Cohesion Biosciences supports scientific discovery across key therapeutic areas including oncology, immunology, and neuroscience by providing reliable tools for signal transduction and cell biology studies. Headquartered in London with significant research and manufacturing facilities in Suzhou, China, the company also provides custom services such as antibody production and peptide synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cohesion Biotec.